Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
4D Molecular Therapeutics
company
About
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $75M
- Industries
- Biotechnology,Genetics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 101 - 250
- Operating Status
- Active
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$165M
4D Molecular Therapeutics has raised a total of
$165M
in funding over 2 rounds. Their latest funding was raised on
Jun 16, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 16, 2020 | Series C | $75M | 1 | — | — | Detail |
| Sep 5, 2018 | Series B | $90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
4D Molecular Therapeutics is funded by 2 investors.
MiraeAsset Financial Group
and CureDuchenne Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
CureDuchenne Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
